Drug Repurposing of Bromodomain Inhibitors as Potential Novel Therapeutic Leads for Lymphatic Filariasis Guided by Multispecies Transcriptomics

mSystems - United States
doi 10.1128/msystems.00596-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

A Novel Multi-Modal Drug Repurposing Approach for Identification of Potent Ack1 Inhibitors

2012English

Albendazole for Lymphatic Filariasis

2004English

MDA—Lymphatic Filariasis

Tropical Medicine and Health
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2014English

Identification of Trypanosoma Cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing

Frontiers in Medicine
Medicine
2019English

Directly Observed Treatment Increases Drug Compliance in Lymphatic Filariasis Mass Drug Administration

Universa Medicina
2016English

Exploring Novel Pharmacotherapeutic Applications and Repurposing Potential of Sodium Glucose CoTransporter 2 (SGLT2) Inhibitors

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

Evaluation of Wuchereria Bancrofti GST as a Vaccine Candidate for Lymphatic Filariasis

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2009English

Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses

Angewandte Chemie - International Edition
CatalysisChemistry
2016English

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy